Frontiers in psychiatry
Usability of digital medicine systems in patients with schizophrenia or schizoaffective disorder
By Kishimoto T, Takano H, Kanzaka R and 11 others.
Abstract
Objective
To assess the usability and performance of digital medication management systems (DMS) for patients with stable ambulatory schizophrenia and schizoaffective disorder.
Methods
This prospective, interventional study comprised a screening phase (up to 4 weeks), training phase (3 weeks: system use under the support), and independent phase (5 weeks under the minimized support) with a follow-up period of 2 weeks. Based on the DSM-5 criteria, patients with a diagnosis of schizophrenia or schizoaffective disorder, taking an atypical antipsychotic as their primary medication, and having access to a smartphone were included in this study.